PL
PL · PL · PL-100511935
Hympavzi
ATC B02BX
Last synced from URPL (Poland) on
Identification
ManufacturerPfizer Europe MA EEIG
CountryPL (PL)
ATC codeB02BX
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Roztwór do wstrzykiwań w ampułko-strzykawce",
"source": "urpl",
"strength": "150 mg/ml",
"packaging": "Rpz ¦ EU/1/24/1874/001 ¦ 159946\n1 amp.-strzyk. 1 ml",
"substance": "Marstacimabum 150 mg/ml",
"common_name": "Marstacimabum",
"pl_product_id": "100511935",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code B02BX.
- 🇺🇸ALVAIZTeva Pharmaceuticals, Inc.
- 🇺🇸ALVAIZTeva Pharmaceuticals, Inc.
- 🇺🇸ALVAIZTeva Pharmaceuticals, Inc.
- 🇺🇸ALVAIZTeva Pharmaceuticals, Inc.
- 🇪🇸DOPTELET 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULASwedish Orphan Biovitrum Ab (Publ)
- 🇺🇸eltrombopagNovadoz Pharmaceuticals LLC
- 🇺🇸eltrombopagDr. Reddy's Laboratories Inc.,
- 🇺🇸eltrombopagDr. Reddy's Laboratories Inc.,
Access this data programmatically
Query Hympavzi and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.